Latest news


PCI Biotech to present clinical data on its phase I/II trial in bile duct cancer at The International Liver Congress 2017

Posted on Apr 6, 2017

Oslo, Norway, April 6, 2017 – PCI Biotech (OSE:PCIB), a clinical-stage company developing innovative therapeutics that address significant unmet medical needs, today announces that clinical data, including emerging interim survival data, from the phase I part of the study in bile duct cancer will be presented during a poster session at The International Liver Congress 2017 […]

PCI Biotech to present at 5th Cancer BioPartnering & Investment Forum

Posted on Mar 28, 2017

Oslo, Norway, March 28, 2017 – PCI Biotech (OSE:PCIB), a clinical-stage company developing innovative therapeutics that address significant unmet medical needs, today announced that it will present the Company at the 5th Annual Cancer BioPartnering & Investment Forum, an event focusing on advances in immune-oncology. The event is taking place at New York Academy of Science, […]

PCI Biotech to present at Bio-Europe Spring 2017

Posted on Mar 22, 2017

Oslo, Norway, March 22, 2017 – PCI Biotech (OSE:PCIB), a clinical-stage company developing innovative therapeutics that address significant unmet medical needs, today announced that it will present at Bio-Europe Spring 2017 being held March 20-22, 2017 at the CCIB Convention Centre, Barcelona, Spain. On Wednesday, March 22, 2017 at 10:30am (CET), Mr. Gaël L’Hévéder, CBDO, will […]